Literature DB >> 22721779

Initiation of HIV-1 reverse transcription and functional role of nucleocapsid-mediated tRNA/viral genome interactions.

Dona Sleiman1, Valérie Goldschmidt, Pierre Barraud, Roland Marquet, Jean-Christophe Paillart, Carine Tisné.   

Abstract

HIV-1 reverse transcription is initiated from a tRNA(Lys)(3) molecule annealed to the viral RNA at the primer binding site (PBS). The annealing of tRNA(Lys)(3) requires the opening of its three-dimensional structure and RNA rearrangements to form an efficient initiation complex recognized by the reverse transcriptase. This annealing is mediated by the nucleocapsid protein (NC). In this paper, we first review the actual knowledge about HIV-1 viral RNA and tRNA(Lys)(3) structures. Then, we summarize the studies explaining how NC chaperones the formation of the tRNA(Lys)(3)/PBS binary complex. Additional NMR data that investigated the NC interaction with tRNA(Lys)(3) D-loop are presented. Lastly, we focused on the additional interactions occurring between tRNA(Lys)(3) and the viral RNA and showed that they are dependent on HIV-1 isolates, i.e. the sequence and the structure of the viral RNA.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22721779     DOI: 10.1016/j.virusres.2012.06.006

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  24 in total

1.  Selection of fully processed HIV-1 nucleocapsid protein is required for optimal nucleic acid chaperone activity in reverse transcription.

Authors:  Tiyun Wu; Robert J Gorelick; Judith G Levin
Journal:  Virus Res       Date:  2014-06-20       Impact factor: 3.303

2.  HIV-1 Pr55Gag binds genomic and spliced RNAs with different affinity and stoichiometry.

Authors:  Serena Bernacchi; Ekram W Abd El-Wahab; Noé Dubois; Marcel Hijnen; Redmond P Smyth; Johnson Mak; Roland Marquet; Jean-Christophe Paillart
Journal:  RNA Biol       Date:  2016-11-14       Impact factor: 4.652

Review 3.  Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy.

Authors:  Divita Garg; Bruce E Torbett
Journal:  Virus Res       Date:  2014-07-12       Impact factor: 3.303

4.  Zinc Fingers in HIV-1 Gag Precursor Are Not Equivalent for gRNA Recruitment at the Plasma Membrane.

Authors:  Emmanuel Boutant; Jeremy Bonzi; Halina Anton; Maaz Bin Nasim; Raphael Cathagne; Eléonore Réal; Denis Dujardin; Philippe Carl; Pascal Didier; Jean-Christophe Paillart; Roland Marquet; Yves Mély; Hugues de Rocquigny; Serena Bernacchi
Journal:  Biophys J       Date:  2020-06-12       Impact factor: 4.033

5.  A protein ballet around the viral genome orchestrated by HIV-1 reverse transcriptase leads to an architectural switch: from nucleocapsid-condensed RNA to Vpr-bridged DNA.

Authors:  Sébastien Lyonnais; Robert J Gorelick; Fatima Heniche-Boukhalfa; Serge Bouaziz; Vincent Parissi; Jean-François Mouscadet; Tobias Restle; Jose Maria Gatell; Eric Le Cam; Gilles Mirambeau
Journal:  Virus Res       Date:  2012-09-24       Impact factor: 3.303

6.  Multiple in Vitro Inhibition of HIV-1 Proteins by 2,6-Dipeptidyl-anthraquinone Conjugates Targeting the PBS RNA.

Authors:  Elia Gamba; Alice Sosic; Irene Saccone; Elisa Magli; Francesco Frecentese; Barbara Gatto
Journal:  ACS Med Chem Lett       Date:  2020-03-23       Impact factor: 4.345

7.  Role of the primer activation signal in tRNA annealing onto the HIV-1 genome studied by single-molecule FRET microscopy.

Authors:  Nancy Beerens; Mette D E Jepsen; Volodymyr Nechyporuk-Zloy; Asger C Krüger; Jean-Luc Darlix; Jørgen Kjems; Victoria Birkedal
Journal:  RNA       Date:  2013-02-12       Impact factor: 4.942

Review 8.  Methylated nucleosides in tRNA and tRNA methyltransferases.

Authors:  Hiroyuki Hori
Journal:  Front Genet       Date:  2014-05-23       Impact factor: 4.599

9.  The Interaction between tRNA(Lys) 3 and the primer activation signal deciphered by NMR spectroscopy.

Authors:  Dona Sleiman; Pierre Barraud; Franck Brachet; Carine Tisne
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

10.  Efficient HIV-1 inhibition by a 16 nt-long RNA aptamer designed by combining in vitro selection and in silico optimisation strategies.

Authors:  Francisco J Sánchez-Luque; Michael Stich; Susanna Manrubia; Carlos Briones; Alfredo Berzal-Herranz
Journal:  Sci Rep       Date:  2014-09-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.